Skip to main content
. Author manuscript; available in PMC: 2021 Sep 8.
Published in final edited form as: Mol Pharm. 2020 Jul 28;17(9):3581–3588. doi: 10.1021/acs.molpharmaceut.0c00606

Figure 2.

Figure 2.

In vitro competitive binding curves of NOTA-GGNle-CycMSHhex (●) and NODAGA-GGNle-CycMSHhex (▲). The IC50 value of NOTA-GGNle-CycMSHhex and NODAGA-GGNle-CycMSHhex was 0.9 ± 0.1 and 0.8 ± 0.05 nM on B10/F10 melanoma cells, respectively.